biOasis Announces the Issuance of an Additional US Patent for the Delivery of Therapeutic Agents Across the Blood-Brain Barrier
VANCOUVER, BC–(Marketwired – July 10, 2016) – biOasis Technologies Inc. (OTCQB: BIOAF) (TSX VENTURE: BTI), a pioneering biopharmaceutical company focused […]
